About Genvax Technologies
Genvax Technologies is a company based in Ames (United States) founded in 2021 by Hank Harris.. Genvax Technologies has raised $9.9 million across 5 funding rounds from investors including Summit Agricultural Group, United States Department of Agriculture and United Animal Health. Genvax Technologies offers products and services including mRNA Nanoparticle Vaccines. Genvax Technologies operates in a competitive market with competitors including HIPRA, Intervacc, VLPbio, Man’s Best Friends Therapeutics and Previwo, among others.
- Headquarter Ames, United States
- Founders Hank Harris
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Genvax Technologies, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$9.9 M (USD)
in 5 rounds
-
Latest Funding Round
-
Investors
Summit Agricultural Group
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Genvax Technologies
Genvax Technologies offers a comprehensive portfolio of products and services, including mRNA Nanoparticle Vaccines. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops vaccines to prevent and treat animal diseases using mRNA technology
Unlock access to complete
Unlock access to complete
Funding Insights of Genvax Technologies
Genvax Technologies has successfully raised a total of $9.9M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Last Round
-
First Round
First Round
(01 Apr 2022)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2025 | Amount | Seed - Genvax Technologies | Valuation | United Animal Health |
|
| Jun, 2024 | Amount | Seed - Genvax Technologies | Valuation |
investors |
|
| Jul, 2023 | Amount | Grant - Genvax Technologies | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Genvax Technologies
Genvax Technologies has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Summit Agricultural Group, United States Department of Agriculture and United Animal Health. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed-stage investments and mentorship are provided to agricultural startups.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Research-based nutrition products are provided for livestock farmers.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Genvax Technologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Genvax Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Genvax Technologies Comparisons
Competitors of Genvax Technologies
Genvax Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as HIPRA, Intervacc, VLPbio, Man’s Best Friends Therapeutics and Previwo, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Vaccines and diagnostic kits for animal diseases are developed.
|
|
| domain | founded_year | HQ Location |
Recombinant vaccines for cattle, equine, and other livestock are developed.
|
|
| domain | founded_year | HQ Location |
Developer of virus like particles as immunotherapies for cancer and infectious diseases
|
|
| domain | founded_year | HQ Location |
Gene-based vaccines for companion animal diseases are developed.
|
|
| domain | founded_year | HQ Location |
Vaccines and probiotics for salmon aquaculture are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Genvax Technologies
Frequently Asked Questions about Genvax Technologies
When was Genvax Technologies founded?
Genvax Technologies was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Where is Genvax Technologies located?
Genvax Technologies is headquartered in Ames, United States. It is registered at Ames, Iowa, United States.
Is Genvax Technologies a funded company?
Genvax Technologies is a funded company, having raised a total of $9.9M across 5 funding rounds to date. The company's 1st funding round was a Grant of $175K, raised on Apr 01, 2022.
What does Genvax Technologies do?
Genvax Technologies was established in 2021 in Ames, United States, within the biotechnology sector. Operations center on the creation of vaccines targeting animal diseases. Emphasis is given to next-generation mRNA-based nanoparticle formulations, which are engineered to activate immune responses in animals. Development activities are conducted to address veterinary health needs through innovative immunization approaches.
Who are the top competitors of Genvax Technologies?
What products or services does Genvax Technologies offer?
Genvax Technologies offers mRNA Nanoparticle Vaccines.
Who are Genvax Technologies's investors?
Genvax Technologies has 7 investors. Key investors include Summit Agricultural Group, United States Department of Agriculture, United Animal Health, Iowa Corn, and Ag Startup Engine.